Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 202
Filter
Add more filters

Publication year range
1.
Acta Derm Venereol ; 102: adv00796, 2022 Oct 19.
Article in English | MEDLINE | ID: mdl-36250769

ABSTRACT

Lichen simplex chronicus is a form of chronic localized pruritus with a secondary dermatitis, and one of the most common types of chronic itch conditions, estimated to affect more than 10% of the general population. However, despite its prevalence and burden, there has been limited research into the pathogenesis and aetiology of lichen simplex chronicus, which, historically, made it a challenging condition to treat. In recent years, our understanding of this condition, along with that of pruritus and the itch-scratch cycle, has increased greatly, enabling a substantial increase in treatment options. In addition, there are several new promising treatments currently in development and trials. This article discusses the definition, epidemiology, clinical characteristics, pathophysiology, and current therapeutic options for lichen simplex chronicus, in order to highlight recent advancements in this field.


Subject(s)
Neurodermatitis , Humans , Neurodermatitis/diagnosis , Neurodermatitis/epidemiology , Neurodermatitis/therapy , Pruritus/diagnosis , Pruritus/epidemiology , Pruritus/etiology
2.
Clin Exp Dermatol ; 47(1): 3-8, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34137059

ABSTRACT

Scalp dysaesthesia, considered a variant of the cutaneous dysaesthesia syndrome, is characterized by chronic sensory symptoms, including pruritus, pain, burning and stinging in a well-defined location, without objective findings. Its aetiology is not well elucidated and treatment options are limited, thus it can be challenging and frustrating for both patient and physician. It can be associated with lichen simplex chronicus. In this paper, we review the literature on the pathogenetic factors, diagnostic methods and therapeutic options in the management of scalp dysaesthesia. Dissociation, cervical spine disease and muscle tension seem to be the most important pathogenetic factors. Trichoscopy, reflectance confocal microscopy and biopsy are all helpful for the diagnosis of the disease. Therapies include high-potency topical or intralesional corticosteroids, capsaicin and topical anaesthetics, sedative antihistamines, tricyclic antidepressants, transcutaneous electric nerve stimulation, botulinum toxin and vitamin B12.


Subject(s)
Neurodermatitis/diagnosis , Neurodermatitis/therapy , Paresthesia/diagnosis , Paresthesia/therapy , Scalp , Humans
3.
Histopathology ; 78(3): 424-433, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32799363

ABSTRACT

AIMS: Differentiated vulvar intraepithelial neoplasia (dVIN), the precursor lesion to human papillomavirus-independent vulvar squamous cell carcinoma (VSCC), can be difficult to distinguish from vulvar inflammatory dermatoses. Our goal was to determine if p53 could be a useful biomarker for dVIN, by characterizing p53 percentage, intensity and patterns of staining in dVIN and its histological mimics. METHODS AND RESULTS: We studied p53 immunohistochemical staining patterns in 16 dVIN cases and 46 vulvar non-neoplastic squamous lesions [12 lichen sclerosus (LS); seven lichen simplex chronicus; three lichen planus (LP); six psoriasis; 13 spongiotic dermatitis (SPO); and five candidiasis]. dVIN cases were adjacent to a p16-negative invasive VSCC in resection specimens. All dVIN cases showed null-type or moderate to strong uniform p53 staining in >70% of basal cells, with moderate to strong continuous parabasal staining extending to two-thirds of the epidermis. This was in contrast to weak or weak to moderate patchy p53 staining in the majority of other lesions. Moderate to strong and increased basal p53 staining (≥70%) was also observed in a subset of LS cases (5/12, 42%), LP cases (1/3, 33%), and SPO cases (36%, 4/11); however, in all categories, this was limited to the basal layer, and any staining in the parabasal layers was patchy. CONCLUSION: Strong and uniform p53 staining of basal cells, extending into the parabasal layers, and a complete absence of staining (null type) is useful in distinguishing dVIN from other mimics in the vulva. p53 staining of lesser intensity or quantity, particularly basal overexpression only, overlaps with that in vulvar inflammatory lesions.


Subject(s)
Carcinoma in Situ/diagnosis , Immunohistochemistry/methods , Tumor Suppressor Protein p53/analysis , Vulvar Neoplasms/diagnosis , Biomarkers, Tumor/analysis , Candidiasis/diagnosis , Candidiasis/pathology , Carcinoma in Situ/pathology , Dermatitis/diagnosis , Dermatitis/pathology , Diagnosis, Differential , Diagnostic Techniques and Procedures , Female , Humans , Lichen Sclerosus et Atrophicus/diagnosis , Lichen Sclerosus et Atrophicus/pathology , Neurodermatitis/diagnosis , Neurodermatitis/pathology , Psoriasis/diagnosis , Psoriasis/pathology , Sensitivity and Specificity , Skin Diseases/diagnosis , Skin Diseases/pathology , Vulva/pathology , Vulvar Neoplasms/pathology
4.
Dermatol Ther ; 33(6): e14389, 2020 11.
Article in English | MEDLINE | ID: mdl-33034929

ABSTRACT

The aim of this study is to evaluate psychiatric comorbidity, temperament and character traits, depression and anxiety levels, and their relation with symptom severity in patients with lichen simplex chronicus (LSC). About 50 patients with LSC were enrolled in the study along with 49 controls. The Structured Clinical Interview for DSM-5 (SCID-5), Temperament and Character Inventory (TCI), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI) were administered to all subjects for psychiatric assessment. Skindex-16 symptom scale was performed for assessing the symptom severity of LSC. LSC group were showing an incidence of 62% in terms of psychiatric comorbidity and 14% of them had two psychiatric diagnoses. The most common psychiatric disorders were major depressive disorder (32%), dysthymia (18%), and generalized anxiety disorder (12%). LSC group had significantly higher mean BDI (18.60 ± 11.77 vs 7.40 ± 4.90) and BAI scores (18.56 ± 13.75 vs 5.18 ± 5.34) than the control group. Patients with LSC displayed higher scores in Harm Avoidance Dimension (19.74 ± 5.18 vs 15.00 ± 5.13) of temperament and regarding character dimensions, they had lower scores in self-directedness (25.52 ± 6.69 vs 29.51 ± 5.54). When analysis of covariance (ANCOVA) was performed while BDI and BAI scores were taken as covariates cooperativeness became significantly higher in the LSC group. Patients with LSC had a high incidence of psychiatric comorbidity, significantly higher depression and anxiety levels, and differed from control group in terms of TCI profile and these conditions were related to symptom severity of the LSC. Comorbid psychiatric conditions and personality traits should be considered as crucial factors for the effective treatment of LSC.


Subject(s)
Depressive Disorder, Major , Neurodermatitis , Character , Comorbidity , Humans , Neurodermatitis/diagnosis , Neurodermatitis/epidemiology , Temperament
5.
Am Fam Physician ; 102(9): 550-557, 2020 11 01.
Article in English | MEDLINE | ID: mdl-33118795

ABSTRACT

Common benign chronic vulvar conditions include genitourinary syndrome of menopause (formerly called vulvovaginal atrophy), lichen sclerosus, lichen planus, lichen simplex chronicus, and vulvodynia. Genitourinary syndrome of menopause results from the hypoestrogenic state that leads to atrophy of normal vulvar and vaginal tissues. It is typically treated with lubricants, moisturizers, and intravaginal estrogen. Lichen sclerosus is an inflammatory condition characterized by intense vulvar itching. It is treated with topical steroids or, in some cases, topical calcineurin inhibitors. Patients with lichen sclerosus are at risk of vulvar squamous cell carcinoma and should be monitored closely for malignancy. Lichen planus is an inflammatory autoimmune disorder that can affect the vulva and vagina in addition to other skin and mucosal surfaces. The first-line treatment is topical steroids, and significant scarring can occur if left untreated. Lichen simplex chronicus manifests as persistent itching and scratching of the vulvar skin that leads to thickened epithelium. Breaking the itch-scratch cycle, often with topical steroids, is the key to treatment. Vulvodynia is a common vulvar pain disorder and is a diagnosis of exclusion. A multimodal treatment approach typically includes vulvar hygiene, physical therapy, psychosocial interventions, and antineuropathy medications.


Subject(s)
Vulvar Diseases/physiopathology , Vulvar Diseases/therapy , Adult , Chronic Disease/drug therapy , Chronic Disease/therapy , Female , Humans , Lichen Planus/diagnosis , Lichen Planus/therapy , Lichen Sclerosus et Atrophicus/diagnosis , Lichen Sclerosus et Atrophicus/therapy , Middle Aged , Neurodermatitis/diagnosis , Neurodermatitis/therapy , Vulva/injuries , Vulva/physiology , Vulva/physiopathology , Vulvar Diseases/diagnosis , Vulvodynia/diagnosis , Vulvodynia/therapy
6.
Int J Gynecol Pathol ; 38(2): 175-182, 2019 Mar.
Article in English | MEDLINE | ID: mdl-29750709

ABSTRACT

High-grade vulvar intraepithelial neoplasia, a precursor lesion to vulvar squamous cell carcinoma, is subdivided into 2 types, classic or usual vulvar intraepithelial neoplasia (CVIN) and differentiated vulvar intraepithelial neoplasia (DVIN). CVIN, which is a human papilloma virus (HPV)-dependent lesion, is typically distinguished from DVIN, a p53 mutation-dependent process, by its distinct histomorphologic and immunohistochemical characteristics. However, distinguishing between the 2 entities becomes challenging in cases of CVIN with superimposed inflammatory changes, especially lichen simplex chronicus (LSC). Twelve cases of DVIN, 9 cases of LSC, and 9 cases of CVIN with superimposed LSC were assessed for a number of morphologic features, including hyperkeratosis, hypergranulosis, acanthosis, hypercellularity, abnormal maturation (i.e. abnormal keratinization close to the base and/or dyskeratosis), hyperchromasia, and basal atypia. Immunohistochemistry for p53, p16, and MIB-1 was performed for all cases. When sufficient tissue was available, HPV genotyping was performed for cases of CVIN with superimposed LSC. DVIN uniformly demonstrated abnormal maturation, and atypia involving the basal cell layer; they were all p16 negative and demonstrated p53 positivity of moderate to strong intensity in a basal and parabasal distribution. CVIN with superimposed LSC frequently displayed hyperchromasia involving the basal 3 to 4 cell layers, basal to full-thickness atypia, and apoptosis. CVIN with superimposed LSC demonstrated intense p16 positivity extending from the basal cells to the mid-epithelium and a reduction or loss of staining in maturing keratinocytes. P53 staining revealed a unique pattern of parabasal and mid-epithelial weak to moderate staining with sparing of the basal layer. Cases of LSC demonstrated heterogenous p53 positivity and were negative for p16. MIB-1 staining showed a similar range of positivity for all diagnoses. HPV genotyping revealed HPV 16 in all 5 cases of CVIN with LSC that underwent testing. We conclude that, although CVIN with superimposed LSC can closely resemble DVIN, morphologic features such as nuclear hyperchromasia uniformly involving the basal 3 to 4 cell layers, apoptosis, and absent or less pronounced cytoplasmic maturation are more suggestive of CVIN with superimposed LSC. In cases where the morphology remains ambiguous, immunohistochemistry for both p16 and p53 can be helpful. In particular, p53 parabasal and mid-epithelial staining without involvement of the basal layer appears to be a characteristic finding in CVIN with superimposed LSC. MIB-1 staining is of little utility in distinguishing between these entities and should not be routinely performed.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma in Situ/diagnosis , Carcinoma, Squamous Cell/diagnosis , Human papillomavirus 16/genetics , Neurodermatitis/diagnosis , Vulvar Neoplasms/diagnosis , Carcinoma in Situ/metabolism , Carcinoma in Situ/pathology , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Diagnosis, Differential , Female , Human papillomavirus 16/isolation & purification , Humans , Immunohistochemistry , Ki-67 Antigen/metabolism , Neurodermatitis/metabolism , Neurodermatitis/pathology , Tumor Suppressor Protein p53/metabolism , Vulvar Neoplasms/metabolism , Vulvar Neoplasms/pathology
7.
Skinmed ; 16(1): 74-75, 2018.
Article in English | MEDLINE | ID: mdl-29551122

ABSTRACT

A 75-year-old man had been monitoring his glucose using a blood glucose monitoring system at the same body site for at least 20 years (>7300 needlesticks). The asymptomatic skin lesion had been present for many years. He used the same site because it hurt less than the fingers and bled well. His medical history was remarkable for diabetes mellitus, hypertension, coronary artery disease, and a pacemaker. His medications included glipizide, metformin, carvedilol, furosemide, lisinopril, amlodipine, clopidogrel, and aspirin. Physical examination revealed a brown, slightly raised, rough plaque with focal, punctate hemorrhagic crusts, on the distal area of the right thigh (Figure 1). The clinical differential diagnosis was more likely to be lichen simplex chronicus than pigmented Bowen's disease. A skin biopsy demonstrated an acanthotic epidermis with coarse collagen bundles in a thickened papillary dermis with extravasated erythrocytes, consistent with a dermal reparative reaction (Figure 2).


Subject(s)
Blood Glucose Self-Monitoring/adverse effects , Neurodermatitis/etiology , Neurodermatitis/pathology , Aged , Biopsy , Humans , Male , Neurodermatitis/diagnosis , Skin/pathology
8.
BMC Cardiovasc Disord ; 15: 173, 2015 Dec 18.
Article in English | MEDLINE | ID: mdl-26681197

ABSTRACT

BACKGROUND: Thalidomide has been reported to cause numerous thromboembolic events. Deep vein thrombosis and pulmonary embolism are more common. It can also cause bradycardia and even total atrioventricular block. Rarely, it causes coronary artery spasm and even myocardial infarction. But almost simultaneous onset of myocardial infarction, third degree atrioventricular block and pulmonary embolism in one patient has not been reported so far. CASE PRESENTATION: A 53-year old man presented because of chest pain, nausea and then syncope for several minutes. Previous medical history included neurodermitis for which thalidomide was given and hypercholesterolemia with simvastatin taking. The patient didn't exhibit any other established risk factors for coronary artery disease. Electrocardiography showed sinus rhythm with third degree atrioventricular block and complete right bundle branch block, and precordial leads ST segment elevation. The diagnosis of acute coronary syndrome was suspected, but further coronary angiography demonstrated no flow-limiting lesions in coronary arteries, and temporary pacemaker was implanted. After admission, low SpO2 and elevated D-dimer level was mentioned. Further computed tomography pulmonary angiography revealed pulmonary embolism. Thalidomide was thought to be the cause of hypercoagulability and coronary spasm, so it was ceased immediately. Therapeutic low molecule weight heparin was initiated and then switched to warfarin with appropriate INR, and nifedipine was described for coronary spasm. The patient's symptoms completely relived and SpO2 recovered, and atrioventricular block had disappeared during hospitalization with pacemaker removed. CONCLUSION: This is the very first case in which myocardial infarction, third degree atrioventricular block and pulmonary embolism almost simultaneously developed. We should be ware that anti-thrombotic prophylaxis, which needs further investigation for optimal drug and dosage, may be beneficial in thalidomide therapy. And it is also important to monitor patients taking thalidomide for signs and symptoms of bradycardia or higher degree atrioventricular block.


Subject(s)
Atrioventricular Block/chemically induced , Dermatologic Agents/adverse effects , Myocardial Infarction/chemically induced , Neurodermatitis/drug therapy , Pulmonary Embolism/chemically induced , Thalidomide/adverse effects , Anticoagulants/therapeutic use , Atrioventricular Block/diagnosis , Atrioventricular Block/therapy , Cardiac Pacing, Artificial , Coronary Angiography , Electrocardiography , Humans , International Normalized Ratio , Magnetic Resonance Imaging , Male , Middle Aged , Myocardial Infarction/diagnosis , Myocardial Infarction/drug therapy , Neurodermatitis/diagnosis , Pulmonary Embolism/diagnosis , Pulmonary Embolism/drug therapy , Severity of Illness Index , Tomography, X-Ray Computed , Treatment Outcome , Vasodilator Agents/therapeutic use
11.
Clin Obstet Gynecol ; 58(3): 464-75, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26125955

ABSTRACT

Inflammatory vulvar dermatoses affect many women, but are likely underdiagnosed due to embarrassment and reluctance to visit a health care provider. Although itch and pain are common presenting symptoms, the physical examination can help distinguish between different disease entities. Because many women's health providers have minimal training in the categorization and management of dermatologic disease, definitive diagnosis and management can be difficult. Herein, strategies for diagnosing vulvar lichen sclerosus, lichen planus, contact dermatitis, lichen simplex chronicus, and psoriasis are discussed along with basic management of these diseases, which commonly involves decreasing inflammation through behavioral change, gentle skin care, topical corticosteroids, and systemic therapies.


Subject(s)
Skin Diseases/diagnosis , Vulvar Diseases/diagnosis , Administration, Cutaneous , Administration, Oral , Adrenal Cortex Hormones/therapeutic use , Dermatitis, Contact/diagnosis , Dermatitis, Contact/therapy , Female , Humans , Lichen Planus/diagnosis , Lichen Planus/therapy , Neurodermatitis/diagnosis , Neurodermatitis/therapy , Psoriasis/diagnosis , Psoriasis/therapy , Skin Care/methods , Skin Diseases/therapy , Vulvar Diseases/therapy , Vulvar Lichen Sclerosus/diagnosis , Vulvar Lichen Sclerosus/therapy , Vulvitis/diagnosis , Vulvitis/therapy
12.
Isr Med Assoc J ; 16(2): 88-90, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24645226

ABSTRACT

BACKGROUND: Localized itch of non-pruritoceptive origin is often neuropathic and may be referred to as neuropathic itch syndrome. OBJECTIVES: To describe the results of nerve conduction studies in patients with anogenital pruritus, brachioradial pruritus and scalp dysesthesia, and compare these sites to typical sites of lichen simplex chronicus (LSC). METHODS: The study summarizes previously published data combined with unpublished data of patients with scalp dysesthesia. Nerve conduction studies included measurements of distal sensory and motor latency, conduction velocity and F-responses. RESULTS: A neuropathy was demonstrated in 29 of 36 patients with anogenital pruritus (80.5%), 8/14 with brachioradial pruritus (57.1%) and 4/9 with scalp dysesthesia (44.4%). The typical sites overlapped with some but not all LSC sites. CONCLUSIONS: A considerable proportion of patients with brachioradial pruritus, anogenital pruritus and scalp dysesthesia have abnormal nerve conduction findings, suggesting a neuropathic origin. The skin sites overlap with some common LSC sites, suggesting that in some cases of LSC a local neuropathy could be a possible cause.


Subject(s)
Antipruritics/administration & dosage , Nerve Block/methods , Neurodermatitis , Peripheral Nervous System Diseases , Pruritus , Administration, Oral , Administration, Topical , Adrenal Cortex Hormones/administration & dosage , Adult , Aged , Anticonvulsants/administration & dosage , Diagnosis, Differential , Electrodiagnosis/methods , Female , Histamine Antagonists/administration & dosage , Humans , Male , Middle Aged , Neural Conduction , Neurodermatitis/diagnosis , Neurodermatitis/physiopathology , Neurodermatitis/therapy , Outcome Assessment, Health Care , Peripheral Nervous System Diseases/complications , Peripheral Nervous System Diseases/diagnosis , Peripheral Nervous System Diseases/physiopathology , Peripheral Nervous System Diseases/therapy , Pruritus/classification , Pruritus/diagnosis , Pruritus/etiology , Pruritus/physiopathology , Pruritus/therapy , Skin/innervation , Skin/pathology
13.
Klin Monbl Augenheilkd ; 231(6): 636-9, 2014 Jun.
Article in German | MEDLINE | ID: mdl-24788604

ABSTRACT

This case report describes a patient with keratoconus and neurodermitis suffering from a significantly prolonged postoperative time interval to re-epithelisation after corneal cross-linking. The development of corneal calcifications and vascularisations additionally inhibited proper re-epithelisation. Therefore the patient received four subsequent subconjunctival injections of Bevacizumab and an additional keratectomy to remove the calcifications. This therapeutic scheme led to a significant reduction of corneal vascularisation and finally a full rehabilitation of the epithelium.


Subject(s)
Corneal Neovascularization/chemically induced , Corneal Neovascularization/physiopathology , Cross-Linking Reagents/adverse effects , Cross-Linking Reagents/therapeutic use , Keratoconus/therapy , Neurodermatitis/complications , Postoperative Complications/chemically induced , Postoperative Complications/physiopathology , Re-Epithelialization/drug effects , Re-Epithelialization/physiology , Adult , Antibodies, Monoclonal, Humanized/administration & dosage , Bevacizumab , Calcinosis/chemically induced , Calcinosis/diagnosis , Calcinosis/physiopathology , Calcinosis/therapy , Combined Modality Therapy , Corneal Neovascularization/diagnosis , Corneal Neovascularization/therapy , Humans , Injections, Intraocular , Keratoconus/diagnosis , Male , Neurodermatitis/diagnosis , Photorefractive Keratectomy , Postoperative Complications/therapy , Riboflavin , Slit Lamp
14.
Z Kinder Jugendpsychiatr Psychother ; 41(1): 35-42; quiz 42-4, 2013 Jan.
Article in German | MEDLINE | ID: mdl-23258436

ABSTRACT

BACKGROUND: Atopic dermatitis (AD) and attention-deficit/hyperactivity disorder (ADHD) are frequent paediatric conditions with high medical relevance. A possible relationship between atopic diseases (i.e., AD, asthma, and allergic rhinitis) has long been discussed, but convincing evidence is still missing. METHODS: We investigated the relationship between AD and ADHD in two cross-sectional studies and in two birth cohort studies considering lifestyle factors, environmental factors, and atopic comorbidities as potential confounders. To quantify the strength of association between AD and ADHD, data from the four epidemiologic studies were summarized by means of a meta-analysis. Odds ratios (OR) were pooled for the association between prevalent or previous AD and prevalent ADHD from the four studies adjusted for age, sex, and atopic comorbidity (allergic rhinitis, asthma). RESULTS: The epidemiologic studies conducted consistently indicate an association between AD and ADHD which is independent of environmental exposures and other comorbidities. Particularly infant AD appears to be associated with later development of ADHD symptoms. Sleeping problems due to AD are suggested as playing an important role for the observed association between AD and ADHD. The pooled OR (95 % confidence interval (95 %CI)) for the association between AD and ADHD was 1.43 (1.25-1.64). DISCUSSION: Four new epidemiologic studies consistently indicate a positive association between AD and ADHD. Compared to children without AD, children with previous or prevalent AD have an approximately 43 % increased risk to be diagnosed with ADHD or to display clinical ADHD symptoms. Following our findings, the biological mechanisms underlying the observed comorbidity between AD and ADHD require further investigation in order to subsequently develop targeted therapeutic and preventive strategies.


Subject(s)
Attention Deficit Disorder with Hyperactivity/epidemiology , Neurodermatitis/epidemiology , Adolescent , Asthma/diagnosis , Asthma/epidemiology , Asthma/psychology , Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/psychology , Child , Cohort Studies , Comorbidity , Cross-Sectional Studies , Humans , Life Style , Longitudinal Studies , Neurodermatitis/diagnosis , Neurodermatitis/psychology , Odds Ratio , Rhinitis, Allergic, Perennial/diagnosis , Rhinitis, Allergic, Perennial/epidemiology , Rhinitis, Allergic, Perennial/psychology , Risk Factors , Sleep Wake Disorders/diagnosis , Sleep Wake Disorders/epidemiology , Sleep Wake Disorders/psychology , Social Environment
15.
Skinmed ; 21(2): 72-81, 2023.
Article in English | MEDLINE | ID: mdl-37158343

ABSTRACT

Annular lichenoid dermatitis of youth (ALDY) is a newly described controversial benign lichenoid inflammatory cutaneous disorder often characterized by annular patches with hypopigmented center and surrounding erythematous border. Primarily, it affects the trunk and groin of young patients. Since its first description in 2003, additional patients have been reported, leading to better characterization of the entity; nevertheless, the pathogenesis is still unclear, and several hypotheses have been provided about possible triggering or causative factors. It tends to follow a chronic course, with some lesions spontaneously remitting, while others may be persistent or recur post-treatment. No standard validated treatment has been indicated so far for this disorder. Commonly prescribed topical treatment includes corticosteroids and calcineurin inhibitors with variable response.


Subject(s)
Lichenoid Eruptions , Neurodermatitis , Humans , Adolescent , Lichenoid Eruptions/diagnosis , Lichenoid Eruptions/etiology , Lichenoid Eruptions/therapy , Skin/pathology , Neurodermatitis/diagnosis , Diagnosis, Differential , Administration, Cutaneous
16.
Lik Sprava ; (5): 35-44, 2012.
Article in Russian | MEDLINE | ID: mdl-23534270

ABSTRACT

An overview of the literature of the dermatitis of the vulva is presented. The etiology, epidemiology, clinical manifestations, diagnosis, pathological diagnosis, treatment, and prevention of contact, allergic-contact, atopic, and seborrheic dermatitis of the vulva are described in details. Lichen simplex chronicus is additionally described as complication of chronic itching dermatitis.


Subject(s)
Dermatitis, Allergic Contact/pathology , Dermatitis, Atopic/pathology , Dermatitis, Irritant/pathology , Dermatitis, Seborrheic/pathology , Eczema/pathology , Neurodermatitis/pathology , Vulva/pathology , Adrenal Cortex Hormones/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Chronic Disease , Dermatitis, Allergic Contact/diagnosis , Dermatitis, Allergic Contact/drug therapy , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/drug therapy , Dermatitis, Irritant/diagnosis , Dermatitis, Irritant/drug therapy , Dermatitis, Seborrheic/diagnosis , Dermatitis, Seborrheic/drug therapy , Diagnosis, Differential , Eczema/diagnosis , Eczema/drug therapy , Female , Histamine Antagonists/therapeutic use , Humans , Neurodermatitis/diagnosis , Neurodermatitis/drug therapy , Vulva/drug effects
18.
J Med Case Rep ; 15(1): 80, 2021 Feb 17.
Article in English | MEDLINE | ID: mdl-33593424

ABSTRACT

INTRODUCTION: Lichen simplex chronicus has been defined as a localized skin condition characterized by thickening, hyperpigmentation and accentuated skin markings from chronic itching and from repeated scratching. The affected skin area is usually described as demarcated, and often circumscribed. It has even been defined as a "psychogenic pruritic disorder". The idea of a neurological component has also been suggested, hence the term 'neurodermatitis circumscripta'. However, the pathophysiology of this condition remains unclear. Several associations and etiologies have been reported in literature, including strong links with mental disorders-anxiety and obsessive compulsive disorder to be specific. We report this case, most importantly, to highlight the value of an open-minded approach to patients and the 'old-fashioned' physician character of empathy, the skill of detailed history taking and physical examination, and lastly to suggest that lichen simplex chronicus may not always present as a localized, 'circumscripta' or demarcated area of skin. CASE DESCRIPTION: When a sixty-five year-old Caucasian female presented to our clinic agitated, intensely scratching her entire body and complaining of severe pruritus, an open-minded detailed approach during history taking and physical examination led to the working diagnosis of diffuse lichenification from chronic scratching secondary to a "possible" cutaneous disorder. Her medical history was unremarkable, but her psychiatric history was significant for Anxiety disorder. She remained on her anxiolytic medication. Her presenting symptom was reported to have persisted for more than 9 months. Review of previous unremarkable lab results and a remarkable findings on detailed skin inspection led to an empiric, trial regimen consisting of three topical preparations: an anti-pruritic-to break the itch-scratch cycle, anti-inflammatory-to curb any inflammatory/immune response and a 'last-ditch' scabicidal application. Follow-up was scheduled, but the patient called the office requesting an earlier follow up appointment. The lesions had significantly improved and the hyper-pigmented, indurated and escoriated skin appearance had resolved; and most importantly, the pruritus. CONCLUSION: Thus we conclude that lichen simplex chronicus may not always present as circumscribed or localized area of skin as currently noted in literature. Also, in patients with psychiatric conditions including anxiety and obsessive-compulsive disorder in particular, effort should be made to avoid stereotyping their presentation as part of their mental disorder spectrum. The value of detailed history and physical examination, mixed with empathy is highlighted. We make our recommendation considering the profound turnaround in the patient's condition and quality of life after several months of emotional and psychological suffering.


Subject(s)
Anxiety Disorders/complications , Neurodermatitis/diagnosis , Pruritus/diagnosis , Scabies/complications , Aged , Diagnostic Errors , Female , Humans , Neurodermatitis/drug therapy , Neurodermatitis/parasitology , Pruritus/drug therapy , Pruritus/parasitology , Scabies/drug therapy
19.
Dermatol Clin ; 39(1): 1-14, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33228853

ABSTRACT

The authors reviewed outpatients in a tertiary dermatology clinic in Botswana to expand knowledge on patterns of skin disease in this population with a high prevalence of human immunodeficiency virus (HIV). Approximately one-third of new and follow-up patients were HIV positive. Common dermatologic conditions included eczematous eruptions, viral and fungal infections, malignant neoplasms, vascular disorders, disorders of pigmentation, and mechanical/physical injury-related disorders. HIV has impacted patterns of dermatologic disease in Botswana, with Kaposi sarcoma being the most frequently biopsied condition. Given the shortage of dermatology specialists, resources should be allocated toward education and management of these most prevalent skin conditions.


Subject(s)
Dermatitis/epidemiology , HIV Infections/epidemiology , Skin Diseases, Infectious/epidemiology , Skin Diseases, Vascular/epidemiology , Skin Neoplasms/epidemiology , Adolescent , Adult , Aged , Biopsy/statistics & numerical data , Botswana/epidemiology , Child , Child, Preschool , Dermatitis/diagnosis , Dermatitis/therapy , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/epidemiology , Dermatitis, Atopic/therapy , Female , Humans , Infant , Lupus Erythematosus, Discoid/diagnosis , Lupus Erythematosus, Discoid/epidemiology , Lupus Erythematosus, Discoid/therapy , Male , Middle Aged , Neurodermatitis/diagnosis , Neurodermatitis/epidemiology , Neurodermatitis/therapy , Prevalence , Retrospective Studies , Sarcoma, Kaposi/diagnosis , Sarcoma, Kaposi/epidemiology , Sarcoma, Kaposi/therapy , Skin Diseases/diagnosis , Skin Diseases/epidemiology , Skin Diseases/therapy , Skin Diseases, Infectious/diagnosis , Skin Diseases, Infectious/therapy , Skin Diseases, Vascular/diagnosis , Skin Diseases, Vascular/therapy , Skin Neoplasms/diagnosis , Skin Neoplasms/therapy , Tertiary Care Centers , Warts/diagnosis , Warts/epidemiology , Warts/therapy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL